Medspan’s Tri-Weekly Newsletter–See What We Have Learned and You Should Know

In May 2015, the Center for Medicare and Medicaid Services (CMS) released a 653-page rule that is likely to create the largest changes in managed Medicaid in over ten years. Read the full blog to learn more.

Here is What MedSpan Research Has Been Up To and Learning: Our Tri-Weekly Newsletter

Recently, a Modern Healthcare survey determined that a majority of healthcare CEOs supported the transition from Fee-For-Service to Value-Based Compensation. However, their time frame of transition varies. Read our blog entry for more on this subject.

How will Medicare Advantage Developments Affect Your Products?

Reductions in federal payments to Medicare Advantage plans have caused split views on enrollment number predictions. Regardless of enrollment outcomes, drug and device manufacturers have certain things they need to keep in mind if they want to be successful.

ACA to Greatly Benefit those with Pre-existing Conditions

Under the Affordable Care Act, those with pre-existing medical conditions cannot be denied health insurance, nor experience higher premiums just because of their conditions. This is likely to cause an increase in market size for healthcare device and therapy manufactures who target patients with pre-existing conditions.